Kura Oncology, Inc.KURANASDAQ
Loading
Cost of Revenue Over TimeStrong
Percentile Rank100
5Y CAGR+80.1%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

5Y CAGR
+80.1%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
18.9x
Strong expansion
Streak
1 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$3.67M-
2024$0.00-100.0%
2023$849000.00-
2022$0.00-
2021$0.00-100.0%
2020$194000.00-
2019$0.00-100.0%
2018$10000.00-66.7%
2017$30000.00-3.2%
2016$31000.00-